Updates from Triluminate and TRISCEND II: Perspectives from the FDA Panel
We Recommend
Disclosures
Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients:
- Equity/Stock(s)/Options - Dura Biotech; Thubrikar Aortic Valve Inc; CardioMech; MicroInterventional Devices; Supira
- Consultant Fee/Honoraria/Speaker's Bureau - Philips; Anteris (Equity as well); Helix Valve Repair
- Grant Support/Research Contract - Edwards Lifesciences; Abbott; Medtronic; Boston Scientific Corporation